High-dose, hyperfractionated, accelerated radiotherapy using a concurrent boost for the treatment of nonsmall cell lung cancer: Unusual toxicity and promising early results

International Journal of Radiation Oncology Biology Physics

Volumn 36, Issue 3, 1996, Pages 593-599

  King, Stephen C ^a,b   Acker, Jeffrey C ^a   Kussin, Peter S ^a   Marks, Lawrence B ^a   Weeks, Kenneth J ^a   Leopold, Kenneth A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Moore Regional Hospital   (United States)

Author keywords

Nonsmall cell lung cancer; Radiation therapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TOXICITY; MALE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; SKIN TOXICITY; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; ESOPHAGUS; FEMALE; HEART; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; RADIATION INJURIES; RADIOTHERAPY DOSAGE; SKIN; SURVIVAL ANALYSIS;

EID: 0030272267     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(96)00353-7     Document Type: Article

References (20)

1. 1. Arriagada, R.; le Chevalier, T.; Quoix, E.; Ruffie, R.; de Cremoux, H.; Douillard, J.; Tarayre, M.; Pignon, J.; Laplanche, A. ASTRO Plenary: Effect of chemotherapy on locally advanced nonsmall cell lung carcinoma: A randomized study of 353 patients. Int. J. Radiat. Oncol. Biol. Phys. 20:1183-1190; 1991.
2. 2. Byhardt, R. W. The evolution of Radiation Therapy Oncology Group (RTOG) protocols for nonsmall cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 32:1513-1525; 1995.
3. 3. Byhardt, R. W.; Pajak, T. R.; Emami, B.; Herskovic, A.; Doggett, R. S.; Olsen, L. A. A phase I/II study to evaluate accelerated fractionation via concomitant boost for squamous, adeno, and large cell carcinoma of the lung: Report of Radiation Therapy Oncology Group 84-07. Int. J. Radiat. Oncol. Biol. Phys. 26:459-468; 1993.
4. 4. Byhardt, R. W.; Scott, C. B.; Ettinger, D. S.; Curran, W. J.; Doggett, R. L. S.; Coughlin, C.; Scarantino, C.; Rotman, M.; Emami, B. Concurrent hyperfractionated irradiation and chemotherapy for unresectable nonsmall cell lung cancer. Results of Radiation Therapy Oncology Group (RTOG) 90-15 (abstr). Lung Cancer 11:188; 1994.
5. 5. Cox, D. R. Regression models and life tables. J. R. Stat. Soc. B. 34:187-220; 1972.
6. 6. Cox, J. D.; Axarnia, N.; Byhardt, R. W.; Shin, K. H.; Emami, B.; Pajak, T. A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60. 0 to 79.2 Gy -Possible survival benefit with = 69.6 Gy in favorable patients with Radiation Therapy Oncology Group Stage III nonsmall cell lung carcinoma. Report of Radiation Therapy Oncology Group 83-11. J. Clin. Oncol. 8:1543-1555; 1990.
7. 7. Dillman, R. O.; Seagren, S. L.; Propert, K. J.; Guerra, J.; Eaton, W. L.; Perry, M. C.; Carey, R. W.; Frei, E. F.; Green, M. R. A randomized trial of induction chemotherapy plus high-dose radiation vs. radiation alone in stage III nonsmall cell lung cancer. N. Engl. J. Med. 323:940-945; 1990.
8. 8. Frank, A.; Lefkowitz, D.; Jaeger, S.; Gobar, L.; Sunderland, J.; Gupta, N.; Scott, W.; Mailliard, J.; Lynch, H.; Bishop, J.; Thorpe, P.; Dewan, N. Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings. Int. J. Radiat. Oncol. Biol. Phys. 32:1495-1512; 1995.
9. 9. Fowler, J. F. The linear-quadratic formula and progress in fractionated radiotherapy. Br. J. Radiol. 62:679-694; 1989.
10. 10. Graham, M. B.; Pajak, T. E.; Herskovic, A. M.; Emami, B.; Perez, C. A. Phase I/II study of treatment of locally advanced (T3/T4) non-oat cell lung cancer with concomitant boost radiotherapy by the Radiation Therapy Oncology Group (RTOG 83-12): Long-term results. Int. J. Radiat. Oncol. Biol. Phys. 31:819-825; 1995.
11. 11. Herskovic, A.; Orton, C.; Seyedsadr, M.; Lattin, P.; Kraut, M.; Han, I.; Ahmad, K.; Holt, J. Initial experience with a practical hyperfractionated accelerated radiotherapy regime. Int. J. Radiat. Oncol. Biol. Phys. 21:1275-1281; 1991.
12. 12. Kaplan, E. L.; Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:457-481; 1958.
13. 13. Kerr, K. M.; Lamb, D. Actual growth rate and tumour cell proliferation in human pulmonary neoplasms. Br. J. Cancer 50:343-349; 1984.
14. 14. Patz, E. F.; Lowe, V. J.; Hoffman, J. M.; Paine, S. S.; Harris, L. K.; Goodman, P. C. Persistent or recurrent bronchogenic carcinoma: Detection with PET and 2-(F-18)-2-deoxy-d-glucose. Radiology 191:379-382; 1994.
15. 15. Perez, C. A.; Stanley, K.; Rubin, P.; Kramer, S.; Brady, L. W.; Marks, J. E.; Perez-Tamayo, R.; Brown, G. S.; Concannon, J. P.; Rotman, M. A prospective randomized study of various irradiation dose fractionation schedules in the treatment of inoperative nonsmall cell lung cancer. Cancer 24:2744-2753; 1980.
16. 16. Saunders, M. I.; Anderson, P.; Dische, S.; Martin, W. M. C. A controlled clinical trial of misonidazole in the radiotherapy of patients with carcinoma of the bronchus. Int. J. Radiat. Oncol. Biol. Phys. 8:347-350; 1982.
17. 17. Saunders, M. I.; Dische, S. Continuous hyperfractionated, accelerated radiotherapy (CHART) in nonsmall cell carcinoma of the bronchus. Int. J. Radiat. Oncol. Biol. Phys. 19:1211-1215; 1990.
18. 18. Sause, W. T.; Scott, C.; Taylor, S.; Byhardt, R. W.; Banker, F. L.; Thomson, H. W.; Jones, T. K.; Cooper, J. S.; Lindberg, R. Phase II trial of combination chemotherapy and irradiation in nonsmall cell lung cancer, Radiation Therapy Oncology Group 88-04. Am. J. Clin. Oncol. 15:163-167; 1992.
19. 19. Sause, W.; Scott, C.; Taylor, S.; Johnson, D.; Livingston, R.; Komaki, R.; Emami, B.; Curran, W. J.; Byhardt, R. W.; Turrisi, A.; Dar, A. R.; Cox, J. D. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG 4588): Preliminary results of a Phase III trial in regionally advanced unresectable nonsmall-cell lung cancer. J. Natl. Cancer Inst. 87:198-205; 1995.
20. 20. Weeks, K. J.; Arora, V. R.; Leopold, K. A.; Light, K. L.; King, S. C.; Ray, S. K.; Sontag, M. R.; Smith, K. D. Clinical use of a concomitant boost technique using a gypsum compensator. Int. J. Radiat. Oncol. Biol. Phys. 30:693-698; 1994.